Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome
US6103702A · kind A · utility
4Cited by
2References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 24, 1999 |
| Grant date | Aug 15, 2000 |
| Priority date | — |
| Expiry date | May 24, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating various-inflammatory conditions, including systemic inflammatory response syndrome (SIRS), septic shock and burns, conditions which may be ameliorated by increased local concentrations of adenosine using adenosine deaminase inhibitors are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.